Both in Pharmaceuticals
Structure Therapeutics vs Mereo BioPharma Group
Over the past year GPCR returned −40.0% and MREO returned −84.0%; their daily moves had a correlation of 0.07.
GPCR −40.0% MREO −84.0%Growth of $1, one year, split-adjusted
| Metric | GPCR | MREO |
|---|---|---|
| Price | $20.35 | $0.2830 |
| Market cap | $1.45B | $45.2M |
| Today | +6.66% | +0.93% |
| 1 month | −20.7% | −24.6% |
| 6 months | −48.0% | +13.4% |
| Year to date | −70.7% | −32.1% |
| 1 year | −36.8% | −84.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $1.34B | — |
| Dividend yield | — | — |
| Volatility (60d) | 59.3% | 78.9% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).